Literature DB >> 19846032

Periprocedural management of anticoagulation and antiplatelet therapies in patients undergoing electrophysiologic procedures.

Jordana Kron1, Daniel Alexander, Mark A Wood.   

Abstract

Electrophysiologic studies, radiofrequency ablation, and device implantations including pacemakers and defibrillators have become essential tools in the armamentarium of electrophysiologists. These procedures are being performed in patients with complex comorbidities, many of whom chronically take anticoagulation or antiplatelet agents. Careful management of anticoagulation before, during, and after electrophysiologic procedures including device implantations is critical to minimize bleeding and thrombotic complications and to optimize patient outcomes.

Entities:  

Year:  2009        PMID: 19846032     DOI: 10.1007/s11936-009-0035-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  40 in total

1.  High incidence of occult femoral vein thrombosis related to multiple venous sheaths during electrophysiological studies.

Authors:  V Davutoglu; S Kervancioglu; H Dinckal; S Soydinc; S Turkmen; I Akdemir; M Aksoy
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients.

Authors:  Ayman S al-Khadra
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

4.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

5.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

6.  A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.

Authors:  G F Michaud; F Pelosi; M D Noble; B P Knight; F Morady; S A Strickberger
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

7.  Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation.

Authors:  Paul Khairy; Patrick Chauvet; John Lehmann; Jean Lambert; Laurent Macle; Jean-François Tanguay; Martin G Sirois; Domenic Santoianni; Marc Dubuc
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

8.  Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Authors:  Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

9.  Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

Authors:  Uwe K H Wiegand; Dominik LeJeune; Frank Boguschewski; Hendrik Bonnemeier; Frank Eberhardt; Heribert Schunkert; Frank Bode
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

Review 10.  Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design.

Authors:  David Birnie; Jeffrey S Healey; Andrew Krahn; Vidal Essebag; Soori Sivakumaran; Anthony Tang; Christopher Simpson
Journal:  Curr Opin Cardiol       Date:  2009-01       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.